KLEMP WALTER V (CEO and President) purchased 1720.0% of their position (533.33K shares) of MOLECULIN BIOTECH, INC. on the open market
Open‑market purchases signal personal conviction — classified as a major conviction buy.
P · 1 purchase
Filed: 8/5/2026ACC: 0001437749-26-025928
DirectorOfficer· CEO and President
Since Jul 2019
+2.13M
Net shares
Net buyer
$0.00
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
2.13M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+533.33K
Price / share
—
Trade value
—
% of position
1720.0%
8/3/2026
31.01K→564.34K
Total
Net shares
+533.33K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/3/2026 | P · Purchase | +533.33K | — | — | 1720.0% | 31.01K | 564.34K |
| Total | +533.33K | $0.00 | ||||||
Derivative Transactions1
Series I Warrants
Direct
Converts to
Common Stock
1.60M shares
Shares
+1.60M
Strike price
Held after
1.93M
Exercisable
—
8/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series I Warrants Direct | Common Stock1.60M shares | 8/3/2026 | A · Award | +1.60M | — | 1.93M |